Cargando…

Elf5 - breast cancer's little helper

A variety of transcription factors has been shown to regulate lineage commitment in the mammary gland and to be associated with different molecular subtypes of breast cancer. E74-like factor 5 (Elf5) has now been identified as a marker of oestrogen receptor status, and high expression correlates wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Frend, Hayley T, Watson, Christine J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672774/
https://www.ncbi.nlm.nih.gov/pubmed/23534926
http://dx.doi.org/10.1186/bcr3397
_version_ 1782272173502627840
author Frend, Hayley T
Watson, Christine J
author_facet Frend, Hayley T
Watson, Christine J
author_sort Frend, Hayley T
collection PubMed
description A variety of transcription factors has been shown to regulate lineage commitment in the mammary gland and to be associated with different molecular subtypes of breast cancer. E74-like factor 5 (Elf5) has now been identified as a marker of oestrogen receptor status, and high expression correlates with more aggressive basal cancers and resistance to anti-oestrogens. Manipulation of Elf5 transcript levels perturbs the molecular profiles of luminal and basal subtypes, highlighting the possibility that targeting Elf5 could provide a new approach for the treatment of basal cancers.
format Online
Article
Text
id pubmed-3672774
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36727742013-09-27 Elf5 - breast cancer's little helper Frend, Hayley T Watson, Christine J Breast Cancer Res Viewpoint A variety of transcription factors has been shown to regulate lineage commitment in the mammary gland and to be associated with different molecular subtypes of breast cancer. E74-like factor 5 (Elf5) has now been identified as a marker of oestrogen receptor status, and high expression correlates with more aggressive basal cancers and resistance to anti-oestrogens. Manipulation of Elf5 transcript levels perturbs the molecular profiles of luminal and basal subtypes, highlighting the possibility that targeting Elf5 could provide a new approach for the treatment of basal cancers. BioMed Central 2013 2013-03-27 /pmc/articles/PMC3672774/ /pubmed/23534926 http://dx.doi.org/10.1186/bcr3397 Text en Copyright © 2013 BioMed Central Ltd
spellingShingle Viewpoint
Frend, Hayley T
Watson, Christine J
Elf5 - breast cancer's little helper
title Elf5 - breast cancer's little helper
title_full Elf5 - breast cancer's little helper
title_fullStr Elf5 - breast cancer's little helper
title_full_unstemmed Elf5 - breast cancer's little helper
title_short Elf5 - breast cancer's little helper
title_sort elf5 - breast cancer's little helper
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672774/
https://www.ncbi.nlm.nih.gov/pubmed/23534926
http://dx.doi.org/10.1186/bcr3397
work_keys_str_mv AT frendhayleyt elf5breastcancerslittlehelper
AT watsonchristinej elf5breastcancerslittlehelper